ALKS Q1 2018 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$225M+17.4% YoY

Gross Profit

$181M80.2% margin

Operating Income

-$62M-27.5% margin

Net Income

-$63M-27.8% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-18.2%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$45M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$581M

Stockholders' Equity

$1.2B

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$225M	$192M	+17.4%
Gross Profit	$181M	$151M	+19.4%
Operating Income	-$62M	-$71M	+12.7%
Net Income	-$63M	-$69M	+9.3%

Revenue Segments

Manufactured Product And Royalty

$115M100%